CSIMarket
 


Grifols Sa  (GRFS)
Other Ticker:  
 

Grifols Sa's Tangible Leverage Ratio

GRFS's quarterly Tangible Leverage Ratio and Total Liabilities, Tangible Equity growth




GRFS Tangible Leverage Ratio (Dec 31 2020)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Dec 31 2019)
IV. Quarter
Y / Y Tangible Equity Change 3.67 % 3.67 % 3.67 % 3.67 % -
Y / Y Total Liabilities Change -1.63 % -1.63 % -1.63 % -1.63 % 11.78 %
Tangible Leverage Ratio MRQ 6.16 6.16 6.16 6.16 6.5
Overall Ranking # # # # #
Seq. Tangible Equity Change 0 % 0 % 0 % 3.67 % 0 %
Seq. Total Liabilities Change 0 % 0 % 0 % -1.63 % 0 %



Tangible Leverage Ratio forth quarter 2020 Comment
Due to repayements of liabilities of 0% Grifols Sa improved Tangible Leverage Ratio in forth quarter 2020 to 6.16, above company's average Tangible Leverage Ratio.

Within Major Pharmaceutical Preparations industry in the forth quarter 2020, 238 other companies have achieved lower Tangible Leverage Ratio than Grifols Sa. While total ranking remained unchanged compare to previous quarter at no. .

Explain Tangible Leverage Ratio?
What is GRFS Market Share?
Tangible Leverage Ratio forth quarter 2020 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 239
Healthcare Sector # 595
Overall Market # 2089


Tangible Leverage Ratio Statistics
High Average Low
2.01 1.55 1.27
(Dec 31 2017)   (Dec 31 2019)




Financial Statements
Grifols Sa's Tangible Equity $ 1,554 Millions Visit GRFS's Balance sheet
Grifols Sa's Total Liabilities $ 9,581 Millions Visit GRFS's Balance sheet
Source of GRFS's Sales Visit GRFS's Sales by Geography




Companies with similar Tangible Leverage Ratio in the quarter endingDec 31 2020, within Major Pharmaceutical Preparations Industry Tangible Leverage RatioDec 31 2020 MRQ Total LiabilitiesDec 31 2020 MRQ Tangible Equity
Novan Inc   15.11 $ 43.852  Millions$ 2.902  Millions
Redhill Biopharma Ltd   12.00 $ 166.377  Millions$ 13.864  Millions
Akebia Therapeutics Inc   8.19 $ 396.521  Millions$ 48.395  Millions
Ironwood Pharmaceuticals inc   7.60 $ 476.280  Millions$ 62.640  Millions
Liminal Biosciences Inc   6.85 $ 78.723  Millions$ 11.499  Millions
Obseva Sa  6.83 $ 57.093  Millions$ 8.354  Millions
Phibro Animal Health Corp  6.28 $ 590.329  Millions$ 94.013  Millions
Grifols Sa  6.16 $ 9,581.288  Millions$ 1,554.318  Millions
Seelos Therapeutics Inc   5.80 $ 14.922  Millions$ 2.572  Millions
Celsion Corp  5.77 $ 18.206  Millions$ 3.155  Millions
Jazz Pharmaceuticals Plc  5.68 $ 2,876.156  Millions$ 506.391  Millions
Karyopharm Therapeutics Inc   5.16 $ 260.587  Millions$ 50.546  Millions
Reviva Pharmaceuticals Holdings Inc   5.11 $ 27.942  Millions$ 5.466  Millions
Dynavax Technologies Corp  4.61 $ 259.790  Millions$ 56.396  Millions
Dicerna Pharmaceuticals Inc   4.14 $ 570.092  Millions$ 137.754  Millions
Cytokinetics Incorporated  3.68 $ 417.635  Millions$ 113.383  Millions
Scynexis inc   3.51 $ 79.778  Millions$ 22.758  Millions
Xeris Pharmaceuticals Inc   3.45 $ 116.517  Millions$ 33.761  Millions
Abvc Biopharma Inc   3.07 $ 8.168  Millions$ 2.662  Millions
Novartis Ag  2.83 $ 75,393.000  Millions$ 26,667.000  Millions
Contrafect Corp  2.76 $ 34.892  Millions$ 12.620  Millions
Sanofi  2.74 $ 57,547.840  Millions$ 21,036.960  Millions
Cumberland Pharmaceuticals Inc   2.65 $ 47.396  Millions$ 17.873  Millions
Apellis Pharmaceuticals inc   2.38 $ 487.157  Millions$ 204.557  Millions
Alnylam Pharmaceuticals Inc   2.35 $ 2,390.814  Millions$ 1,016.247  Millions
Insmed Inc  2.30 $ 520.271  Millions$ 226.623  Millions
F star Therapeutics Inc   2.27 $ 20.615  Millions$ 9.082  Millions
Rigel Pharmaceuticals Inc  2.24 $ 76.352  Millions$ 34.026  Millions
Onconova Therapeutics Inc   2.20 $ 13.585  Millions$ 6.175  Millions
Ocular Therapeutix Inc   2.17 $ 164.862  Millions$ 76.095  Millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

AMIH's Profile

Stock Price

AMIH's Financials

Business Description

Fundamentals

Charts & Quotes

AMIH's News

Suppliers

AMIH's Competitors

Customers & Markets

Economic Indicators

AMIH's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071